{
    "organizations": [],
    "uuid": "8f2a10a46e9b7e81ca9a42e115beb1c89e216dad",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/idUSH9N1PV01S",
    "ord_in_thread": 0,
    "title": "CORRECTED-BRIEF-Livzon Pharmaceutical Unit's JV Livzon Biologics' Capital Will Be Boosted By 600 Mln Yuan (Feb 7)",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "(Corrects currency unit in headline and bullet point to yuan, not U.S. dollar)\nFeb 7 (Reuters) - Livzon Pharmaceutical Group Inc :\n* SAYS CAPITAL AT UNIT'S JV LIVZON BIOLOGICS WILL BE BOOSTED BY 600 MILLION YUAN ($94.94 million) Source text in Chinese: bit.ly/2nMWH27 Further company coverage: ($1 = 6.3201 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-02-07T20:06:00.000+02:00",
    "crawled": "2018-02-09T16:32:13.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "corrects",
        "currency",
        "unit",
        "headline",
        "bullet",
        "point",
        "yuan",
        "dollar",
        "feb",
        "reuters",
        "livzon",
        "pharmaceutical",
        "group",
        "inc",
        "say",
        "capital",
        "unit",
        "jv",
        "livzon",
        "biologics",
        "boosted",
        "million",
        "yuan",
        "million",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}